Trials / Completed
CompletedNCT00092209
Antihypertensive Efficacy and Safety of Approved Drugs in Japanese Patients With Essential Hypertension (Banyu Study)(0954A-302)
A Randomized, Placebo-Controlled, Double-Blind, Parallel Study of the Anti-Hypertensive Efficacy and Safety of Losartan Monotherapy as Compared to HCTZ Monotherapy and to the Combination of Losartan and HCTZ in Japanese Patients With Essential Hypertension
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 840 (planned)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 25 Years – 74 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate antihypertensive (lowering blood pressure) effectiveness of three combinations of approved study drugs compared to both study drugs being given alone.
Detailed description
The duration of treatment is 3.5 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MK0954A, hydrochlorothiazide (+) losartan potassium | |
| DRUG | Comparator: placebo, losartan, hydrochlorothiazide |
Timeline
- Start date
- 2002-04-01
- Primary completion
- 2002-11-01
- Completion
- 2002-11-01
- First posted
- 2004-09-24
- Last updated
- 2022-02-15
Source: ClinicalTrials.gov record NCT00092209. Inclusion in this directory is not an endorsement.